New hope for uncontrollable movements? drug study aims to ease debilitating side effect
NCT ID NCT05859698
Summary
This study tested whether the drug valbenazine could improve daily life for people with tardive dyskinesia (TD), a condition causing uncontrollable movements often linked to certain mental health medications. For 24 weeks, 59 adults with TD and conditions like schizophrenia or bipolar disorder took valbenazine. Researchers measured changes in how the movements affected their ability to function, their daily activities, and their overall quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TARDIVE DYSKINESIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Neurocrine Clinical Site
Bryant, Arkansas, 72022, United States
-
Neurocrine Clinical Site
Anaheim, California, 92805, United States
-
Neurocrine Clinical Site
Orange, California, 92868, United States
-
Neurocrine Clinical Site
Torrance, California, 90504, United States
-
Neurocrine Clinical Site
Bonita Springs, Florida, 34134, United States
-
Neurocrine Clinical Site
Miami, Florida, 33176, United States
-
Neurocrine Clinical Site
Miami Lakes, Florida, 33016, United States
-
Neurocrine Clinical Site
Okeechobee, Florida, 34972, United States
-
Neurocrine Clinical Site
Tampa, Florida, 33629, United States
-
Neurocrine Clinical Site
Atlanta, Georgia, 30328, United States
-
Neurocrine Clinical Site
Augusta, Georgia, 30912, United States
-
Neurocrine Clinical Site
Marietta, Georgia, 30060, United States
-
Neurocrine Clinical Site
Lincoln, Nebraska, 68526, United States
-
Neurocrine Clinical Site
Beechwood, Ohio, 44122, United States
-
Neurocrine Clinical Site
Oklahoma City, Oklahoma, 73112, United States
-
Neurocrine Clinical Site
DeSoto, Texas, 75115, United States
-
Neurocrine Clinical Site
El Paso, Texas, 79902, United States
-
Neurocrine Clinical Site
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.